bnt162b2
Showing 1 - 4 of 4
COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)
Active, not recruiting
- COVID-19
- Ad26COVS1
- +3 more
-
Vienna, AustriaMedicial University of Vienna
Apr 12, 2022
Adaptive Immune Response to COVID-19 Vaccination
Active, not recruiting
- SARS-CoV-2 Vaccination
- BNT162b2
- +2 more
-
Greifswald, MV, GermanyUniversity Medicine Greifswald
Mar 25, 2022
Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,
Recruiting
- Rheumatoid Arthritis
- +8 more
- Moderna mRNA-1273
- +5 more
-
Los Angeles, California
- +24 more
Aug 17, 2022